293 related articles for article (PubMed ID: 28587952)
1. The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
Li R; Tang X; Jing Q; Wang Q; Yang M; Han X; Zhao J; Yu X
Am J Emerg Med; 2017 Nov; 35(11):1657-1661. PubMed ID: 28587952
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
Tang X; Gong J
Cardiol Res Pract; 2022; 2022():7674366. PubMed ID: 35818572
[TBL] [Abstract][Full Text] [Related]
3. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
[TBL] [Abstract][Full Text] [Related]
4. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
[TBL] [Abstract][Full Text] [Related]
5. Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry.
Kim JS; Kim CH; Chun KJ; Kim JH; Park YH; Kim J; Choi JH; Lee SH; Kim EJ; Yu DG; Ahn EY; Jeong MH
Clin Res Cardiol; 2013 Dec; 102(12):915-22. PubMed ID: 23982468
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention.
Bonello L; Sbragia P; Amabile N; Com O; Pierre SV; Levy S; Paganelli F
Heart; 2007 Jun; 93(6):703-7. PubMed ID: 17488771
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional speckle tracking echocardiography to evaluate left ventricular function in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention following Tongxinluo treatment.
Qin W; Tian R; Feng J; Zhai Z; Wang Z; Huang L; Lu G; Dong S
J Clin Ultrasound; 2022 Nov; 50(9):1229-1239. PubMed ID: 36054138
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of elevated troponin I after percutaneous coronary intervention.
Cantor WJ; Newby LK; Christenson RH; Tuttle RH; Hasselblad V; Armstrong PW; Moliterno DJ; Califf RM; Topol EJ; Ohman EM;
J Am Coll Cardiol; 2002 Jun; 39(11):1738-44. PubMed ID: 12039485
[TBL] [Abstract][Full Text] [Related]
9. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Wang C; Chen W; Yu M; Yang P
Angiology; 2021 Jul; 72(6):511-523. PubMed ID: 33472383
[TBL] [Abstract][Full Text] [Related]
11. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention.
Shehata M
Am J Cardiol; 2014 Aug; 114(3):389-94. PubMed ID: 24927970
[TBL] [Abstract][Full Text] [Related]
12. Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.
Gulmez O; Yildirir A; Kaynar G; Konas D; Aydinalp A; Ertan C; Ozin B; Muderrisoglu H
J Thromb Thrombolysis; 2008 Jun; 25(3):239-46. PubMed ID: 17574519
[TBL] [Abstract][Full Text] [Related]
13. [Clinical outcomes of trimetazidine in patients with acute ST segment elevation myocardial infarction without ST segment resolution after primary percutaneous coronary intervention].
Peng JJ; Ma ZM; Ren WL; Ren LH; Lei LC; Liang Y
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1399-401. PubMed ID: 19671333
[TBL] [Abstract][Full Text] [Related]
14. Assessment of left ventricle diastolic function in myocardial infarction patients treated with primary angioplasty.
Misztal M; Stopyra K; Gackowski A; Zmudka K; Piwowarska W
Cardiol J; 2009; 16(5):440-6. PubMed ID: 19753523
[TBL] [Abstract][Full Text] [Related]
15. Different postconditioning cycles affect prognosis of aged patients undergoing primary percutaneous coronary intervention.
Zhang J; Zhang X; Cui Y; Ferdous M; Cui L; Zhao P
Cardiol J; 2018; 25(6):666-673. PubMed ID: 28714526
[TBL] [Abstract][Full Text] [Related]
16. Influence of trimetazidine on myocardial injury in mice with diabetic cardiomyopathy.
Zhao D; Ma J; Sun Y; Huang W; Fan J; Ye M; Hu B; Sun X
J Diabetes Complications; 2024 May; 38(5):108744. PubMed ID: 38613990
[TBL] [Abstract][Full Text] [Related]
17. Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial.
Dai ZL; Song YF; Tian Y; Li Y; Lin M; Lin J; Wang Q; Wang P; Gao WL
BMC Cardiovasc Disord; 2021 Oct; 21(1):473. PubMed ID: 34598676
[TBL] [Abstract][Full Text] [Related]
18. Effect of a 180 mg ticagrelor loading dose on myocardial necrosis in patients undergoing elective percutaneous coronary intervention: A preliminary study.
Xu Q; Sun Y; Zhang Y; Liu B; Fang L; Shen C; Li Y; Meng S
Cardiol J; 2017; 24(1):15-24. PubMed ID: 28070882
[TBL] [Abstract][Full Text] [Related]
19. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
20. Effects of trimetazidine administration before thrombolysis in patients with anterior myocardial infarction: short-term and long-term results.
Di Pasquale P; Lo Verso P; Bucca V; Cannizzaro S; Scalzo S; Maringhini G; Rizzo R; Paterna S
Cardiovasc Drugs Ther; 1999 Sep; 13(5):423-8. PubMed ID: 10547222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
